Apyx Medical Corporation
APYX
$1.99
-$0.03-1.49%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 46.51M | 47.29M | 48.10M | 48.54M | 49.03M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 46.51M | 47.29M | 48.10M | 48.54M | 49.03M |
| Cost of Revenue | 17.85M | 18.21M | 18.74M | 19.22M | 18.68M |
| Gross Profit | 28.67M | 29.08M | 29.36M | 29.33M | 30.35M |
| SG&A Expenses | 37.09M | 39.87M | 43.13M | 45.53M | 47.29M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 58.82M | 62.57M | 66.95M | 70.12M | 71.61M |
| Operating Income | -12.31M | -15.28M | -18.85M | -21.57M | -22.58M |
| Income Before Tax | -17.05M | -19.89M | -23.31M | -28.27M | -28.60M |
| Income Tax Expenses | 247.00K | 248.00K | 252.00K | 250.00K | -128.00K |
| Earnings from Continuing Operations | -17.29 | -20.14 | -23.56 | -28.52 | -28.48 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 34.00K | 104.00K | 96.00K | 82.00K | 107.00K |
| Net Income | -17.26M | -20.04M | -23.46M | -28.44M | -28.37M |
| EBIT | -12.31M | -15.28M | -18.85M | -21.57M | -22.58M |
| EBITDA | -11.75M | -14.70M | -18.25M | -20.96M | -21.92M |
| EPS Basic | -0.45 | -0.55 | -0.66 | -0.82 | -0.82 |
| Normalized Basic EPS | -0.28 | -0.34 | -0.41 | -0.45 | -0.46 |
| EPS Diluted | -0.45 | -0.55 | -0.66 | -0.82 | -0.82 |
| Normalized Diluted EPS | -0.28 | -0.34 | -0.41 | -0.45 | -0.46 |
| Average Basic Shares Outstanding | 154.32M | 148.23M | 142.15M | 138.58M | 138.57M |
| Average Diluted Shares Outstanding | 154.32M | 148.23M | 142.15M | 138.58M | 138.57M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |